Santa Monica, CA5 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Santa Monica, CA

Find 5 actively recruiting myalgic encephalomyelitis clinical trials in Santa Monica, CA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
2,135
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Santa Monica

About Myalgic Encephalomyelitis Clinical Trials in Santa Monica

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 5 myalgic encephalomyelitis clinical trials recruiting participants in Santa Monica, CA. These studies are seeking a combined 2,135 participants. Research is being sponsored by Novartis Pharmaceuticals, Immunocore Ltd, Takeda and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Santa Monica — FAQ

Are there myalgic encephalomyelitis clinical trials in Santa Monica?

Yes, there are 5 myalgic encephalomyelitis clinical trials currently recruiting in Santa Monica, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 5 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated October 12, 2026 from ClinicalTrials.gov